16 articles for LT Bacheler
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Functionalized aliphatic P2/P2′ analogs of HIV-1 protease inhibitor DMP323

TBA
Synthesis of (+)-biotin derivatives as HIV-1 protease inhibitors

TBA
Synthesis, antiviral activity and pharmacokinetics of P1/P1' substituted 3-aminoindazole cyclic urea HIV protease inhibitors.

Bristol-Myers Squibb
Unsymmetrical cyclic ureas as HIV-1 protease inhibitors: novel biaryl indazoles as P2/P2' substituents.

Dupont Pharmaceuticals
The synthesis and evaluation of cyclic ureas as HIV protease inhibitors: modifications of the P1/P1' residues.

Dupont Pharmaceuticals
Nonsymmetric P2/P2' cyclic urea HIV protease inhibitors. Structure-activity relationship, bioavailability, and resistance profile of monoindazole-substituted P2 analogues.

Dupont Pharmaceuticals
Cyclic urea amides: HIV-1 protease inhibitors with low nanomolar potency against both wild type and protease inhibitor resistant mutants of HIV.

Dupont Pharmaceuticals
Aryl sultam derivatives as RORc modulators

Genentech
Compositions, methods, and systems for the synthesis and use of imaging agents

Lantheus Medical Imaging
Substituted 1,7-naphthyridines as dopamine D1 ligands

Pfizer
Fused tricyclic amide compounds as multiple kinase inhibitors

Beigene
Heteroaryl compounds and methods of use thereof

Sunovion Pharmaceuticals
PRMT5 inhibitors and uses thereof

Epizyme
5-chloro-3-(phenylsulfonyl)indole-2-carboxamide: a novel, non-nucleoside inhibitor of HIV-1 reverse transcriptase.

Merck Research Laboratories
Aminodiol HIV protease inhibitors. Synthesis and structure-activity relationships of P1/P1' compounds: correlation between lipophilicity and cytotoxicity.

Bristol-Myers Squibb
Synthesis and structure-activity relationships of a series of penicillin-derived HIV proteinase inhibitors containing a stereochemically unique peptide isostere.

Glaxo Group Research